Your browser doesn't support javascript.
loading
Non-permissive SARS-CoV-2 infection in human neurospheres.
Pedrosa, Carolina da S G; Goto-Silva, Livia; Temerozo, Jairo R; Souza, Leticia R Q; Vitória, Gabriela; Ornelas, Isis M; Karmirian, Karina; Mendes, Mayara A; Gomes, Ismael C; Sacramento, Carolina Q; Fintelman-Rodrigues, Natalia; Cardoso Soares, Vinicius; Silva Gomes Dias, Suelen da; Salerno, José A; Puig-Pijuan, Teresa; Oliveira, Julia T; Aragão, Luiz G H S; Torquato, Thayana C Q; Veríssimo, Carla; Biagi, Diogo; Cruvinel, Estela M; Dariolli, Rafael; Furtado, Daniel R; Borges, Helena L; Bozza, Patrícia T; Rehen, Stevens; Moreno L Souza, Thiago; Guimarães, Marília Zaluar P.
Affiliation
  • Pedrosa CDSG; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Goto-Silva L; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Temerozo JR; National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
  • Souza LRQ; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Vitória G; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Ornelas IM; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Karmirian K; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Mendes MA; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Gomes IC; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Sacramento CQ; Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cru
  • Fintelman-Rodrigues N; Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cru
  • Cardoso Soares V; Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Program of Immunology and Inflammation, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Silva Gomes Dias SD; Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
  • Salerno JA; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Puig-Pijuan T; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Oliveira JT; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Aragão LGHS; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Torquato TCQ; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Veríssimo C; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Biagi D; Pluricell Biotech, São Paulo, SP, Brazil.
  • Cruvinel EM; Pluricell Biotech, São Paulo, SP, Brazil.
  • Dariolli R; Pluricell Biotech, São Paulo, SP, Brazil; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Furtado DR; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
  • Borges HL; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Bozza PT; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
  • Rehen S; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Institute of Biology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address:
  • Moreno L Souza T; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Program of Immunology and Inflammation, Federal University of Rio de Jan
  • Guimarães MZP; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address: marilia@lance-ufrj.org.
Stem Cell Res ; 54: 102436, 2021 07.
Article in En | MEDLINE | ID: mdl-34186311
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Stem Cell Res Year: 2021 Document type: Article Affiliation country: Brasil
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Stem Cell Res Year: 2021 Document type: Article Affiliation country: Brasil